Where is the live CopyMark page for USPTO serial 86773265?

The live record is at https://getcopymark.com/trademark/86773265. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns SERENUS BIOTHERAPEUTICS?

According to the public USPTO record for serial number 86773265, the listed owner(s) include: Serenus Biotherapeutics Limited.

What is USPTO serial number 86773265?

Serial number 86773265 is the USPTO application identifier for the mark SERENUS BIOTHERAPEUTICS. It is used to track examination, publication, and registration of this trademark.

What is the current status of SERENUS BIOTHERAPEUTICS?

SERENUS BIOTHERAPEUTICS (86773265) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover SERENUS BIOTHERAPEUTICS?

The public record lists International Classes: 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: SERENUS BIOTHERAPEUTICS Serial# 86773265 | status 601; last event MAB1 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SERENUS BIOTHERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Serenus Biotherapeutics Limited
IFSC, Dublin 1, IE
Other trademarks owned by Serenus Biotherapeutics Limited

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dorothy Auth

Dorothy Auth Cadwalader, Wickersham & Taft LLPOne World Financial CenterNew York, NY 10281UNITED STATES

Goods and services

Class	Description	Status	First use
042	Pharmaceutical drug development services; Pharmaceutical product evaluation	ACTIVE	Jun 18, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Feb 23, 2016	MAB1	ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT	—
Feb 23, 2016	ABN1	ABANDONMENT - EXPRESS MAILED	—
Feb 22, 2016	EXAR	TEAS EXPRESS ABANDONMENT RECEIVED	—
Feb 22, 2016	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2016	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Jan 29, 2016	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 29, 2016	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 29, 2016	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2016	DOCK	ASSIGNED TO EXAMINER	—
Oct 6, 2015	MDSC	NOTICE OF DESIGN SEARCH CODE E-MAILED	—
Oct 5, 2015	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Oct 3, 2015	NWAP	NEW APPLICATION ENTERED	—

SERENUS BIOTHERAPEUTICS